Abstract
One of the drawbacks preventing the use of mesenchymal stem cells (MSCs) in clinical practice is the heterogeneous nature of their cultures. MSC cultures are not homogeneously formed by the MSCs and may contain non-mesenchymal cell types. Therefore, prior to use in clinics or research, complete characterization of MSCs should be performed to demonstrate the existence or absence of proper stem cell markers, many of which are happened to be cell-surface proteins. Unfortunately, the success of MSC characterization studies is limited due to the low specificity of the currently available cell-surface markers. Therefore, in this study, we aimed to investigate the plasma membrane (PM) proteins of MSCs isolated from human dental pulp (DP), adipose tissue (AT), bone marrow (BM), and hair follicle (HF) with the hope of proposing novel putative specific MSC markers. Differential-velocity centrifugation was used to enrich PM proteins. The isolated proteins were then identified by nLC-MS/MS and subjected to bioinformatics analysis. Proteins that were unique to each MSC type (CD9, CD10, CD63 for DP-MSCs; CD26, CD81, CD201, CD364 for AT-MSCs; Cd49a, CD49d for HF-MSCs; CD49e, CD56, CD92, CD97, CD156b, CD156c, CD220, CD221, CD298, CD315 for BM-MSCs) and common to all four MSC types (CD13, CD29, CD44, CD51, CD59, CD73, CD90) were identified. Uncharacterized proteins that have transmembrane (TM) domains were also detected. Some of the proteins identified in this study were the putative cell-surface markers that might be used for characterization of MSCs.
Graphic Abstract
Similar content being viewed by others
Data Availability
If acquired, the raw data for LC–MS/MS experiments will be provided via e-mail.
References
Abdallah BM, Kassem M (2008) Human mesenchymal stem cells: from basic biology to clinical applications. Gene Ther 15:109–116
Araya HF, Sepulveda H, Lizama CO, Vega OA, Jerez S, Briceno PF, Thaler R, Riester SM, Antonelli M, Salazar-Onfray F, Rodriguez JP, Moreno RD, Montecino M, Charbonneau M, Dubois CM, Stein GS, van Wijnen AJ, Galindo MA (2018) Expression of the ectodomain-releasing protease ADAM17 is directly regulated by the osteosarcoma and bone-related transcription factor RUNX2. J Cell Biochem 119:8204–8219
Baker N, Zhang G, You Y, Tuan RS (2012) Caveolin-1 regulates proliferation and osteogenic differentiation of human mesenchymal stem cells. J Cell Biochem 113:3773–3787
Billing AM, Ben Hamidane H, Dib SS, Cotton RJ, Bhagwat AM, Kumar P, Hayat S, Yousri NA, Goswami N, Suhre K, Rafii A, Graumann J (2016) Comprehensive transcriptomic and proteomic characterization of human mesenchymal stem cells reveals source specific cellular markers. Sci Rep 6:21507
Bruno L, Hoffmann R, McBlane F, Brown J, Gupta R, Joshi C, Pearson S, Seidl T, Heyworth C, Enver T (2004) Molecular signatures of self-renewal, differentiation, and lineage choice in multipotential hemopoietic progenitor cells in vitro. Mol Cell Biol 24:741–756
Bundgaard L, Stensballe A, Elbaek KJ, Berg LC (2018) Mapping of equine mesenchymal stromal cell surface proteomes for identification of specific markers using proteomics and gene expression analysis: an in vitro cross-sectional study. Stem Cell Res Ther 9:288
Cappellesso-Fleury S, Puissant-Lubrano B, Apoil PA, Titeux M, Winterton P, Casteilla L, Bourin P, Blancher A (2010) Human fibroblasts share immunosuppressive properties with bone marrow mesenchymal stem cells. J Clin Immunol 30:607–619
Deschaseaux F, Gindraux F, Saadi R, Obert L, Chalmers D, Herve P (2003) Direct selection of human bone marrow mesenchymal stem cells using an anti-CD49a antibody reveals their CD45med, low phenotype. Br J Haematol 122:506–517
Dhaliwal A, Brenner M, Wolujewicz P, Zhang Z, Mao Y, Batish M, Kohn J, Moghe PV (2016) Profiling stem cell states in three-dimensional biomaterial niches using high content image informatics. Acta Biomater 45:98–109
Dollet PE, Ravau J, Andre F, Najimi M, Sokal E, Lombard C (2016) Comprehensive screening of cell surface markers expressed by adult-derived human liver stem/progenitor cells harvested at passage 5: potential implications for engraftment. Stem Cells Int 2016:9302537
Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, Deans R, Keating A, Prockop D, Horwitz E (2006) Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8:315–317
Engel P, Boumsell L, Balderas R, Bensussan A, Gattei V, Horejsi V, Jin BQ, Malavasi F, Mortari F, Schwartz-Albiez R, Stockinger H, van Zelm MC, Zola H, Clark G (2015) CD Nomenclature 2015: human leukocyte differentiation antigen workshops as a driving force in immunology. J Immunol 195:4555–4563
Ertas G, Ural E, Ural D, Aksoy A, Kozdag G, Gacar G, Karaoz E (2012) Comparative analysis of apoptotic resistance of mesenchymal stem cells isolated from human bone marrow and adipose tissue. Sci World J 2012:105698
Ferro F, Spelat R, Beltrami AP, Cesselli D, Curcio F (2012) Isolation and characterization of human dental pulp derived stem cells by using media containing low human serum percentage as clinical grade substitutes for bovine serum. PLoS ONE 7:e48945
Folgiero V, Migliano E, Tedesco M, Iacovelli S, Bon G, Torre ML, Sacchi A, Marazzi M, Bucher S, Falcioni R (2010) Purification and characterization of adipose-derived stem cells from patients with lipoaspirate transplant. Cell Transplant 19:1225–1235
Foster LJ, Zeemann PA, Li C, Mann M, Jensen ON, Kassem M (2005) Differential expression profiling of membrane proteins by quantitative proteomics in a human mesenchymal stem cell line undergoing osteoblast differentiation. Stem Cells 23:1367–1377
Gaudet P, Livstone MS, Lewis SE, Thomas PD (2011) Phylogenetic-based propagation of functional annotations within the Gene Ontology consortium. Brief Bioinform 12:449–462
Graneli C, Thorfve A, Ruetschi U, Brisby H, Thomsen P, Lindahl A, Karlsson C (2014) Novel markers of osteogenic and adipogenic differentiation of human bone marrow stromal cells identified using a quantitative proteomics approach. Stem Cell Res 12:153–165
Halfon S, Abramov N, Grinblat B, Ginis I (2011) Markers distinguishing mesenchymal stem cells from fibroblasts are downregulated with passaging. Stem Cells Dev 20:53–66
Helbig AO, Heck AJ, Slijper M (2010) Exploring the membrane proteome–challenges and analytical strategies. J Proteom 73:868–878
Horwitz EM, Le Blanc K, Dominici M, Mueller I, Slaper-Cortenbach I, Marini FC, Deans RJ, Krause DS, Keating A (2005) Clarification of the nomenclature for MSC: The International Society for Cellular Therapy position statement. Cytotherapy 7:393–395
Kane MS, Diamonstein CJ, Hauser N, Deeken JF, Niederhuber JE, Vilboux T (2019) Endosomal trafficking defects in patient cells with KIAA1109 biallelic variants. Genes Dis 6:56–67
Karaoz E, Dogan BN, Aksoy A, Gacar G, Akyuz S, Ayhan S, Genc ZS, Yuruker S, Duruksu G, Demircan PC, Sariboyaci AE (2010) Isolation and in vitro characterisation of dental pulp stem cells from natal teeth. Histochem Cell Biol 133:95–112
Karaoz E, Demircan PC, Saglam O, Aksoy A, Kaymaz F, Duruksu G (2011) Human dental pulp stem cells demonstrate better neural and epithelial stem cell properties than bone marrow-derived mesenchymal stem cells. Histochem Cell Biol 136:455–473
Ke AW, Shi GM, Zhou J, Huang XY, Shi YH, Ding ZB, Wang XY, Devbhandari RP, Fan J (2011) CD151 amplifies signaling by integrin alpha6beta1 to PI3K and induces the epithelial-mesenchymal transition in HCC cells. Gastroenterology 140:1629–1641
Kovacs GG, Trabattoni G, Hainfellner JA, Ironside JW, Knight RS, Budka H (2002) Mutations of the prion protein gene phenotypic spectrum. J Neurol 249:1567–1582
Kundrotas G (2012) Surface markers distinguishing mesenchymal stem cells from fibroblasts. Acta Medica Litu 19:75–79
Li C, Zhao H, Wang B (2021) Mesenchymal stem/stromal cells: developmental origin, tumorigenesis and translational cancer therapeutics. Transl Oncol 14:100948
Lisianyi MI (2013) Mesenchymal stem cells and their immunological properties. Fiziol Zh 59:126–134
Maleki M, Ghanbarvand F, Reza Behvarz M, Ejtemaei M, Ghadirkhomi E (2014) Comparison of mesenchymal stem cell markers in multiple human adult stem cells. Int J Stem Cells 7:118–126
Mihaylova Z (2019) Stem cells and mesenchymal stem cell markers. Int J Med Sci Clin Invent 6:4544–45477
Niehage C, Steenblock C, Pursche T, Bornhauser M, Corbeil D, Hoflack B (2011) The cell surface proteome of human mesenchymal stromal cells. PLoS ONE 6:e20399
Niehage C, Karbanova J, Steenblock C, Corbeil D, Hoflack B (2016) Cell surface proteome of dental pulp stem cells identified by label-free mass spectrometry. PLoS ONE 11:e0159824
Nunez-Gomez E, Pericacho M, Ollauri-Ibanez C, Bernabeu C, Lopez-Novoa JM (2017) The role of endoglin in post-ischemic revascularization. Angiogenesis 20:1–24
Orsburn BC, Stockwin LH, Newton DL (2011) Challenges in plasma membrane phosphoproteomics. Expert Rev Proteom 8:483–494
Pionneau C, Canelle L, Bousquet J, Hardouin J, Bigeard J, Caron M, Joubert-Caron R (2005) Proteomic analysis of membrane-associated Proteins from the Breast Cancer Cell Line MCF7. Cancer Genom Proteom 2:199–207
Ramos TL, Sanchez-Abarca LI, Muntion S, Preciado S, Puig N, Lopez-Ruano G, Hernandez-Hernandez A, Redondo A, Ortega R, Rodriguez C, Sanchez-Guijo F, del Canizo C (2016) MSC surface markers (CD44, CD73, and CD90) can identify human MSC-derived extracellular vesicles by conventional flow cytometry. Cell Commun Signal 14:2
Razani B, Woodman SE, Lisanti MP (2002) Caveolae: from cell biology to animal physiology. Pharmacol Rev 54:431–467
ten Dijke P, Goumans MJ, Pardali E (2008) Endoglin in angiogenesis and vascular diseases. Angiogenesis 11:79–89
Torán JL, López JA, Gomes-Alves P, Aguilar S, Torroja C, Trevisan-Herraz M, Moscoso I, Sebastião MJ, Serra M, Brito C, Cruz FM (2019) Definition of a cell surface signature for human cardiac progenitor cells after comprehensive comparative transcriptomic and proteomic characterization. Sci Rep 9(1):1–6
Tsuruya K, Chikada H, Ida K, Anzai K, Kagawa T, Inagaki Y, Mine T, Kamiya A (2015) A paracrine mechanism accelerating expansion of human induced pluripotent stem cell-derived hepatic progenitor-like cells. Stem Cells Dev 24:1691–1702
Uezumi A, Nakatani M, Ikemoto-Uezumi M, Yamamoto N, Morita M, Yamaguchi A, Yamada H, Kasai T, Masuda S, Narita A, Miyagoe-Suzuki Y, Takeda S, Fukada S, Nishino I, Tsuchida K (2016) Cell-surface protein profiling identifies distinctive markers of progenitor cells in human skeletal muscle. Stem Cell Rep 7:263–278
Verrier S, Hogan A, McKie N, Horton M (2004) ADAM gene expression and regulation during human osteoclast formation. Bone 35:34–46
Vidal-Laliena M, Romero X, March S, Requena V, Petriz J, Engel P (2005) Characterization of antibodies submitted to the B cell section of the 8th Human Leukocyte Differentiation Antigens Workshop by flow cytometry and immunohistochemistry. Cell Immunol 236:6–16
Wetzig A, Alaiya A, Al-Alwan M, Pradez CB, Pulicat MS, Al-Mazrou A, Shinwari Z, Sleiman GM, Ghebeh H, Al-Humaidan H, Gaafar A, Kanaan I, Adra C (2013) Differential marker expression by cultures rich in mesenchymal stem cells. BMC Cell Biol 14:54
Yin K, Wang S, Zhao RC (2019) Exosomes from mesenchymal stem/stromal cells: a new therapeutic paradigm. Biomark Res 7:8
Yoneten KK, Kasap M, Akpinar G, Kanli A, Karaoz E (2019) Comparative proteomics analysis of four commonly used methods for identification of novel plasma membrane proteins. J Membr Biol 252:587–608
Yu H, Fang D, Kumar SM, Li L, Nguyen TK, Acs G, Herlyn M, Xu X (2006) Isolation of a novel population of multipotent adult stem cells from human hair follicles. Am J Pathol 168:1879–1888
Zola H (2004) High-sensitivity immunofluorescence/flow cytometry: detection of cytokine receptors and other low-abundance membrane molecules. Curr Protoc Cytom. https://doi.org/10.1002/0471142956.cy0603s30
Zola H, Swart B, Nicholson I, Aasted B, Bensussan A, Boumsell L, Buckley C, Clark G, Drbal K, Engel P, Hart D, Horejsi V, Isacke C, Macardle P, Malavasi F, Mason D, Olive D, Saalmueller A, Schlossman SF, Schwartz-Albiez R, Simmons P, Tedder TF, Uguccioni M, Warren H (2005) CD molecules 2005: human cell differentiation molecules. Blood 106:3123–3126
Acknowledgements
This work was supported by The Scientific and Technological Research Council of Turkey (TUBITAK) with the grant number of 113S868. The funding body had no role in the design or execution of the study.
Funding
This work was supported by The Scientific and Technological Research Council of Turkey (TUBITAK) under the grant number of 113S868.
Author information
Authors and Affiliations
Contributions
GA: Experimental design, carrying out experiments, writing the manuscript. KKY: Experimental design, carrying out experiments. MK: Experimental design, carrying out experiments, writing the manuscript. EK: Stem cell isolation and characterization experiments.
Corresponding author
Ethics declarations
Conflicts of interest
The authors have no conflict of interest.
Ethical approval
The MSC lines used in this study were previously isolated and used in several studies of ours. Their ethical approvals for isolation were granted by Kocaeli University Ethics Committee.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Akpinar, G., Yoneten, K.K., Kasap, M. et al. Search for Novel Plasma Membrane Proteins as Potential Biomarkers in Human Mesenchymal Stem Cells Derived from Dental Pulp, Adipose Tissue, Bone Marrow, and Hair Follicle. J Membrane Biol 254, 409–422 (2021). https://doi.org/10.1007/s00232-021-00190-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00232-021-00190-1